Exact Sciences Corporation (NASDAQ:EXAS) is at least 321.38% than its current record low price of $13.05. There was a 9.76% gain on Oct. 31, 2017 that led the price to move at $54.99. At recent session, the prices were hovering between $53.72 and $57.95. This company shares are -9.73% up from its target price of $49.64 and the current market capitalization stands at $6.32B. The recent change has given its price a 21.8% lead over SMA 50 and 6.36% lead over its 52-week high. The stock witnessed 14.71% gains, 45.13% gains and 75.63% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found EXAS’s volatility during a week at 4.55% and during a month it has been found around 3.32%.Exact Sciences Corporation (EXAS) Top Holders
Institutional investors currently hold around $5.19 billion or 87.4% in EXAS stock. Look at its top three institutional owners. Vanguard Group Inc owns $473.93 million in Exact Sciences Corporation, which represents roughly 7.5% of the company’s market cap and approximately 9.13% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 6,884,886 shares of the stock are valued at $344.93 million. The third largest holder is Primecap Management Co/Ca/, which currently holds $225.52 million worth of this stock and that ownership represents nearly 3.57% of its market capitalization.Exact Sciences Corporation 13F Filings
At the end of 06/30/2017 reporting period, 143 institutional holders increased their position in Exact Sciences Corporation (NASDAQ:EXAS) by some 19,796,625 shares, 125 decreased positions by 19,168,389 and 30 held positions by 64,609,658. That puts total institutional holdings at 103,574,672 shares, according to SEC filings. The stock grabbed 61 new institutional investments totaling 8,900,590 shares while 27 institutional investors sold out their entire positions totaling 2,799,428 shares.Exact Sciences Corporation (NASDAQ:EXAS) Insider Trades
Multiple company employees have indulged in significant insider trading. Exact Sciences Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that SVP and General Counsel Coward D Scott has sold 29,115 shares of Exact Sciences Corporation (EXAS) in trading session dated Oct. 02, 2017. These shares are worth $1,373,063 and were traded at $47.16 each. The SEC filing shows that Lidgard Graham Peter performed a sale of 81,025 shares. The Chief Science Officer disposed these shares by way of transaction on Oct. 02, 2017. The company’s shares were given away at $47.16 per share worth to an income of some $3,821,139 on account of Lidgard Graham Peter.
Chief Science Officer, Lidgard Graham Peter, sold 75,683 common shares of Exact Sciences Corporation (EXAS) in the open market. In a transaction dated Sep. 05, 2017, the shares were put up for sale at an average price of $40.81, raking in a sum of $3,088,623. After this sale, 343,283 common shares of EXAS are directly owned by the insider, with total stake valued at $18,877,132.
In the transaction dated Sep. 01, 2017, the great number of shares disposed came courtesy the Chief Science Officer; Lidgard Graham Peter disposed a total of 45,775 shares at an average price of $41.49, amounting to approximately $1,899,205. The insider now directly owns 300,966 shares worth $16,550,120.Exact Sciences Corporation (EXAS) Analyst Guide
Several analysts have released their opinion on Exact Sciences Corporation (NASDAQ:EXAS), with 9 analysts believing it is a strong buy. Whereas 3 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.5 average brokerage recommendation.